Vitamin D and Stroke

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-09-01

Study Completion Date

2017-01-03

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Stroke remains one of the most devastating neurological diseases, often causing death, or gross physical impairment. It is the second most common cause of death worldwide and a major cause of acquired disability in adults.Vitamin D deficiency has been reported to contribute to the risk of cardiovascular disease especially stroke.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Hypovitaminosis D in Neurocritical Patients

NCT02881957

Craniocerebral Trauma Intracranial Aneurysm Brain Neoplasms +7 more

COMPLETED PHASE2/PHASE3

Vitamin D Effect on Subarachnoid Hemorrhage

NCT03482843

Vitamin D Deficiency

UNKNOWN

Vitamin D Deficiency as Independent Predictor for Plaque Vulnerability

NCT06473337

Vitamin D Deficiency Carotid Artery Diseases

COMPLETED

The Effect of Vitamin D Statues on Endothelial Function

NCT01049048

Cardiovascular Diseases Vitamin D Deficiency

COMPLETED EARLY_PHASE1

Role of Vitamin D in Secondary Prevention of Cardiovascular Events

NCT01018849

Cardiovascular Disease

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This case -control observational prospective study will conducted on fifty patients with first -ever acute onset stroke within seven days (25 patients with hemorrhagic stroke and 25 patients with ischemic stroke )

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group 1 (hemorrhagic stroke)

All participants will be subjected to thorough history taking, full clinical and neurological examination. Stroke subtype will be classified according to the criteria of Trial of Org 10172 in acute Stroke Treatment (TOAST) classification.

Vit D

Intervention Type DIETARY_SUPPLEMENT

It is to examine the relationship between serum 25 (OH) D levels and Stroke either ischemic or hemorrhagic types

Group 2 (Ischemic stroke)

All participants will be subjected to thorough history taking, full clinical and neurological examination. Stroke subtype will be classified according to the criteria of Trial of Org 10172 in acute Stroke Treatment (TOAST) classification.

Vit D

Intervention Type DIETARY_SUPPLEMENT

It is to examine the relationship between serum 25 (OH) D levels and Stroke either ischemic or hemorrhagic types

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Vit D

It is to examine the relationship between serum 25 (OH) D levels and Stroke either ischemic or hemorrhagic types

Intervention Type DIETARY_SUPPLEMENT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Onset is within one week
* Confirmed stroke by brain CAT and / or MRI scan either haemorrhage or infarction

Exclusion Criteria

* Cognitive and mental changes
* Recurrent stroke
* Hepatic and renal impairment
* Endocrinal diseases
* Steroid therapy
* Vitamin D or Ca supplementation
* Previous fractures
* Bone diseases
* brain neoplasm,
* Autoimmune diseases
* History of acute and chronic inflammatory diseases
* Malignancy,
* Trauma
* Surgery
* Acute vascular diseases that occurred within four weeks prior the onset of stroke
* History myocardial infarction ˂3 months.

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No